Literature DB >> 30776340

The Global Paradigm Shift in Screening for Colorectal Cancer.

Graeme P Young1, Linda Rabeneck2, Sidney J Winawer3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30776340     DOI： 10.1053/j.gastro.2019.02.006

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  22 in total

1.  Colorectal cancer screening: It is not time for a radical shift.

Authors:  Barbara Bielawska; Catherine Dubé
Journal:  CMAJ       Date:  2020-01-20       Impact factor: 8.262

Review 2.  Non-Invasive Colorectal Cancer Screening: An Overview.

Authors:  Melanie Tepus; Tung On Yau
Journal:  Gastrointest Tumors       Date:  2020-05-20

Review 3.  Colon and Rectal Cancer Management in Low-Resource Settings.

Authors:  Sonja Boatman; Harika Nalluri; Wolfgang B Gaertner
Journal:  Clin Colon Rectal Surg       Date:  2022-09-13

4.  Examining the Factors That Affect the Diagnosis of Patients with Positive Fecal Occult Blood Test Results.

Authors:  Yin-Wen Cheng; Ying-Chun Li
Journal:  Int J Environ Res Public Health       Date:  2022-06-21       Impact factor: 4.614

5.  Estimating the impact of insurance expansion on colorectal cancer and related costs in North Carolina: A population-level simulation analysis.

Authors:  Kristen Hassmiller Lich; Meghan C O'Leary; Siddhartha Nambiar; Rachel M Townsley; Maria E Mayorga; Karen Hicklin; Leah Frerichs; Paul R Shafer; Melinda M Davis; Stephanie B Wheeler
Journal:  Prev Med       Date:  2019-10-27       Impact factor: 4.018

6.  MiR-130b-3p promotes colorectal cancer progression by targeting CHD9.

Authors:  Dan Song; Qian Zhang; Hao Zhang; Liangliang Zhan; Xinchen Sun
Journal:  Cell Cycle       Date:  2022-01-31       Impact factor: 4.534

7.  GGCT promotes colorectal cancer migration and invasion via epithelial-mesenchymal transition.

Authors:  Qi Huang; Yuanhang Zhou; Yue Li; Zhiwei Liao
Journal:  Oncol Lett       Date:  2020-05-30       Impact factor: 2.967

8.  Biomarker measurement in non-invasively sampled colorectal mucus as a novel approach to colorectal cancer detection: screening and triage implications.

Authors:  Alexandre Loktionov; Anet Soubieres; Tatiana Bandaletova; Nader Francis; Joanna Allison; Julian Sturt; Jai Mathur; Andrew Poullis
Journal:  Br J Cancer       Date:  2020-05-13       Impact factor: 7.640

9.  miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.

Authors:  Xueni Xu; Xiaoxiang Chen; Mu Xu; Xiangxiang Liu; Bei Pan; Jian Qin; Tao Xu; Kaixuan Zeng; Yuqin Pan; Bangshun He; Huiling Sun; Li Sun; Shukui Wang
Journal:  Aging (Albany NY)       Date:  2019-09-22       Impact factor: 5.682

10.  Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.

Authors:  Szu-Min Peng; Wen-Feng Hsu; Ying-Wei Wang; Li-Ju Lin; Amy Ming-Fang Yen; Li-Sheng Chen; Yi-Chia Lee; Ming-Shiang Wu; Tony Hsiu-Hsi Chen; Han-Mo Chiu
Journal:  Gut       Date:  2020-09-28       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.